Home

GRO — Deck

Brazil Potash Corp · GRO · NYSE American

A $2.27B Amazon mine wrapped in a $175M ticker — project-finance call option or dilution trap

$3.24
CMP (Apr 16, 2026)
$176M
Market Cap
0.90x
P/B (no P/E — pre-revenue)
13.9 mo
Cash Runway
Down 78% from $15 IPO, 91% of 2.4Mtpy presold on take-or-pay, BTIG mandated Nov 2025 to raise $1.5–2.0B of project equity
1 · Business

A single-asset Amazon potash developer — not an operating company

  • The asset. Autazes Potash Project in Amazonas — 2.4Mtpy nameplate, $2.27B capex, $3.08B management NPV, $78.70/ton opex.
  • The moat thesis. 2.5-day river-barge transit to Brazilian farmers vs 107 days for Belarusian imports; ~$50–80/ton freight arbitrage.
  • The revenue stack. Three take-or-pay offtakes — Amaggi 551k + Keytrade 900k + Kimia 704k tons/yr — cover ~91% of planned production on 10–17 year tenors.
  • The gap. Zero revenue, $140M of capitalized project spend, ~$2.2B of capex still to raise against a $176M equity.
Moat is location, not orebody — but Mosaic Fertilizantes already operates inside Brazil and will defend share
2 · Numbers

Pre-revenue developer — the balance sheet is the story, dilution is the clock

$0
FY25 Revenue (19 years, zero sales)
$52M
FY25 Net Loss ($42M non-cash SBC)
54.2M
Shares Out (was 35.7M at Nov-24 IPO)
$27.8M
Cash (vs $2.5B capex ahead)

Strip out the $42M of stock-based comp and real cash burn is ~$10M; but capex is ramping and 52% dilution in two years signals the next raise is when-not-if.

3 · People

Grade C — marquee chairman, near-zero skin in the game

  • Credibility upgrade. Mayo Schmidt (ex-Nutrien CEO, ex-Viterra, ex-Hydro One chair) joined as Executive Chairman Jan 2025 — real resume at a micro-cap.
  • Skin-in-the-game gap. Named insiders purchased <$600K of stock against $11.5M FY25 comp; CFO, Corporate Secretary and two directors own zero shares.
  • Original backer exit. Sentient liquidated its entire 3.86M-share position at $2.00 on Nov 12, 2025 — left ~$4.8M of mark-to-market on the table.
  • Structural architecture. Every exec paid via personal LLC, F&M consulting agreement locked in to 2032 at $1M/yr, 36-month change-of-control triggers.
A single $500K+ open-market buy by Schmidt or Simpson would reset the alignment narrative — it hasn't happened
4 · Story

19 years, $280M spent, never broken ground — now on the one-yard line

Era 1 — Permitting purgatory (2006–2023): Incorporated by Forbes & Manhattan in Ontario to develop Autazes; $274M raised across 18 years of private placements; PEL granted 2015, voluntarily suspended 2017 for ILO 169 Mura consultations; federal prosecutor suspension 2023 overturned on appeal.

Era 2 — Commercial validation, financing gap (2024–present): Downsized NYSE American IPO Nov 2024 at $15 (now $3.24); all 21 Construction Licenses obtained; three take-or-pay offtakes signed 2024–25; Schmidt and Vale-veteran Sergio Leite hired; BTIG mandated Nov 3, 2025 for $1.5–2.0B project equity; debt talks ongoing for $1.7–1.8B.

Historian credibility 6/10 — hits on procedural milestones (permits, offtakes, legal wins), misses on construction and financing timing
5 · Web Intel

Commercial thesis quietly de-risked while alignment thesis weakened

  • BTIG mandated Nov 3, 2025. Lead advisor for $1.5–2.0B of project-level equity; Reuters confirms $1.7–1.8B debt talks with banks — the make-or-break catalyst.
  • Sentient Form 4 sale, Nov 14, 2025. Original PE backer sold $7.7M — eleven days after the BTIG mandate — the highest-impact insider signal on record.
  • Cantor initiates Speculative Buy, Dec 16, 2025. Independent BeyondSPX models 15–20% completion probability with 5–10x upside if funded, 80–90% loss if not.
Morningstar $9.86 fair value vs Danelfin $6.17 AI target — 6:1 dispersion is the signal: this is binary, not DCF
6 · Risks

Four risks that matter — all interconnected, all financing-adjacent

  • Financing gap. $2.2B of capex still to raise against a $176M cap; any equity shortfall cannot be funded at parent without destroying holders.
  • Dilution engineering. 28M potential shares added in Oct-25 PP (14M warrants at $3.00 strike — exactly current price); $75M Alumni ELOC drawing at market.
  • Timing track record. Construction start slipped H1-25 → 2026; debt tranche mid-25 → H2-26; IBA 2025 → 2026; the goalpost is rolling.
  • Federal prosecutor overhang. May 2024 refiling of the 2016 jurisdictional challenge remains active; adverse lower-court ruling reopens permit risk even if ultimately overturned.
7 · What's Next

One question dominates 2026 — does project financing close before cash runs out

  • Jun 2026. BTIG project-finance update — any strategic at $300M+ on Autazes SPV is the single largest potential rerate; silence past mid-year is itself a signal.
  • Jul 2026. Power transmission line permit — the last permit outstanding; grant = construction-ready, denial = 6–12 month delay.
  • Oct 2026. Federal prosecutor civil suit progress — dismissal matches the June 2025 TRF-1 pattern; adverse ruling reopens permit risk.
  • Dec 2026. Management-guided H2 2026 debt close (~$1.5B senior tranche) — another slip = third timing miss on the central milestone.
  • Q1 2027. First construction spend at scale — the one milestone the company has never delivered in 19 years.
The market is pricing ~30–40% probability that construction gets financed — every catalyst shifts that by a few points
8 · For & Against

Lean cautious — correctly-priced optionality, not mispriced

  • For. ~91% offtake coverage on 10–17 year take-or-pay is the mechanical unlock lenders need for the H2 2026 debt tranche — not in the $176M cap (Warren).
  • For. Mayo Schmidt + Sergio Leite + Franco-Nevada option = real credibility arbitrage; ex-Nutrien CEOs don't take micro-cap roles without conviction on a deliverable (Sherlock).
  • For. $176M cap vs $3.08B management NPV (or $1.8B at 40% haircut) with one calendared decision to resolve the binary — asymmetry is structural (Quant/Warren).
  • Against. Sentient liquidated entire position at $2.00 in Nov 2025 while insiders bought <$600K against $11.5M of comp — alignment signal runs the wrong way (Sherlock).
  • Against. 52% dilution in two years, $75M ELOC drawing at market, 14M warrants struck at current price — capital structure engineered for dilution (Quant).
  • Against. Construction start has been '18 months away' for 18 months; the one thing never delivered in 19 years is the one now on the 2026 calendar (Historian).
My View — The tipping item is the Sentient exit at $2 coinciding with zero meaningful insider buying at $3.24; a BTIG-led project-level equity close at $800M+ for a minority Autazes stake flips it.

Watchlist to re-rate: BTIG project-equity term sheet at $800M+ Autazes valuation, $500K+ open-market buy by Schmidt or Simpson, any new federal court injunction on the installation license